STEPHANIE QUIST: Open Payments
NPI 1104394717 · ROCKFORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,888 in 85 payments from 17 companies in 2025. Trend: 2023 $309 · 2024 $945 · 2025 $1,888
Food & beverage: $1,789Education: $99
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 12 | $285 |
| Janssen Biotech, Inc. | 7 | $207 |
| UCB, Inc. | 8 | $203 |
| Regeneron Healthcare Solutions, Inc. | 11 | $178 |
| Novartis Pharmaceuticals Corporation | 7 | $173 |
| LEO Pharma Inc. | 8 | $150 |
| GENZYME CORPORATION | 5 | $132 |
| PFIZER INC. | 5 | $91 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $80 |
| Lilly USA, LLC | 4 | $79 |
Products named: OPZELURA, DUPIXENT, TREMFYA, Bimzelx, COSENTYX, ADBRY, ILUMYA, OTEZLA.
Industry payments across MI — which companies pay providers there.
